Heart inflammation following Covid vaccination rare: Lancet study
SINGAPORE: The overall risk of myopericarditis -- a condition that causes inflammation of the heart muscles -- following Covid-19 vaccination is very low, affecting 18 people per million vaccine doses, according to a study published in The Lancet Respiratory Medicine journal. The research confirms that the risk of myopericarditis is comparable to or lower following Covid-19 vaccination than other non-Covid-19 vaccines. The team analysed international databases, looking at over 400 million vaccination doses, to compare the risk of myopericarditis following vaccination against Covid-19 and other diseases such as influenza and smallpox. They found no statistically significant difference between the incidence of myopericarditis following Covid-19 vaccination -- 18 cases per million doses -- and other vaccinations, which was 56 cases per million doses. "Our research suggests that the overall risk of myopericarditis appears to be no different for this newly approved group of vaccine...